Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty

This publication has 19 references indexed in Scilit:

• Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study
  Acta Endocrinologica, 1994
• Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.
  Circulation, 1993
• Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries.
  Circulation, 1993
• Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy
  Journal of the American College of Cardiology, 1993
• Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells
  European Journal of Biochemistry, 1992
• Clinical trials of restenosis after coronary angioplasty.
  Circulation, 1991
• Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
  Circulation, 1990
• Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide
  Atherosclerosis, 1989
• Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.
  Circulation, 1989
• Exposure to Platelet-Derived Growth Factor Modulates the Porcine Aortic Smooth Muscle Cell Response to Somatomedin-C*
  Endocrinology, 1985